For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.
Testing the Addition of the Antibody Atezolizumab to Usual Chemotherapy after Surgery in Patients with Colon Cancer
To compare any good and bad effects of using the drug atezolizumab along with the usual chemotherapy compared to the usual chemotherapy alone.
DiagnosisStage III Colon cancer
Stage III colon cancer that has been removed by surgery.
Patients must sign an approved informed consent and authorization permitting release of personal health information.
Group 1: Chemotherapy plus atezolizumab for 6 months, then atezolizumab alone for 6 months
Group 2: Chemotherapy for 6 months
- Quality of Life surveys
After completion of the study patients will be followed for 8 years
For more information, visit ClinicalTrials.gov